Clinical Trials List
Protocol NumberADG126-1001
Completed
2022-04-18 - 2023-05-16
Phase I
Recruiting2
Terminated1
-
Trial Applicant
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/02/01
Investigators and Locations
Co-Principal Investigator
- Jih-Hsiang Lee 無
- Wei-Wu Chen 無
- 徐偉勛 無
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Tsu-Yi Chao 無
- 莊博雅 Division of Hematology & Oncology
- 溫國璋 Division of Hematology & Oncology
- Wei-Hong Cheng Division of Hematology & Oncology
- HUI-WEN LIU Division of Hematology & Oncology
- Hung-Cheng Lai Division of Hematology & Oncology
- 朱凌慧 Division of Hematology & Oncology
- Yao-Yu Hsieh Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Terminated
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
20 participants
-
Global
146 participants
